Screening and identification of DNA nucleic acid aptamers against F1 protein of Yersinia pestis using SELEX method.


Journal

Molecular biology reports
ISSN: 1573-4978
Titre abrégé: Mol Biol Rep
Pays: Netherlands
ID NLM: 0403234

Informations de publication

Date de publication:
03 Jun 2024
Historique:
received: 19 11 2023
accepted: 16 04 2024
medline: 3 6 2024
pubmed: 3 6 2024
entrez: 3 6 2024
Statut: epublish

Résumé

Yersinia pestis is a bacterium that causes the disease plague. It has caused the deaths of many people throughout history. The bacterium possesses several virulence factors (pPla, pFra, and PYV). PFra plasmid encodes fraction 1 (F1) capsular antigen. F1 protein protects the bacterium against host immune cells through phagocytosis process. This protein is specific for Y. pestis. Many diagnostic techniques are based on molecular and serological detection and quantification of F1 protein in different food and clinical samples. Aptamers are small nucleic acid sequences that can act as specific ligands for many targets.This study, aimed to isolate the high-affinity ssDNA aptamers against F1 protein. In this study, SELEX was used as the main strategy in screening aptamers. Moreover, enzyme-linked aptamer sorbent assay (ELASA) and surface plasmon resonance (SPR) were used to determine the affinity and specificity of obtained aptamers to F1 protein. The analysis showed that among the obtained aptamers, the three aptamers of Yer 21, Yer 24, and Yer 25 were selected with a KD value of 1.344E - 7, 2.004E - 8, and 1.68E - 8 M, respectively. The limit of detection (LoD) was found to be 0.05, 0.076, and 0.033 μg/ml for Yer 21, Yer 24, and Yer 25, respectively. This study demonstrated that the synthesized aptamers could serve as effective tools for detecting and analyzing the F1 protein, indicating their potential value in future diagnostic applications.

Sections du résumé

BACKGROUND BACKGROUND
Yersinia pestis is a bacterium that causes the disease plague. It has caused the deaths of many people throughout history. The bacterium possesses several virulence factors (pPla, pFra, and PYV). PFra plasmid encodes fraction 1 (F1) capsular antigen. F1 protein protects the bacterium against host immune cells through phagocytosis process. This protein is specific for Y. pestis. Many diagnostic techniques are based on molecular and serological detection and quantification of F1 protein in different food and clinical samples. Aptamers are small nucleic acid sequences that can act as specific ligands for many targets.This study, aimed to isolate the high-affinity ssDNA aptamers against F1 protein.
METHODS AND RESULTS RESULTS
In this study, SELEX was used as the main strategy in screening aptamers. Moreover, enzyme-linked aptamer sorbent assay (ELASA) and surface plasmon resonance (SPR) were used to determine the affinity and specificity of obtained aptamers to F1 protein. The analysis showed that among the obtained aptamers, the three aptamers of Yer 21, Yer 24, and Yer 25 were selected with a KD value of 1.344E - 7, 2.004E - 8, and 1.68E - 8 M, respectively. The limit of detection (LoD) was found to be 0.05, 0.076, and 0.033 μg/ml for Yer 21, Yer 24, and Yer 25, respectively.
CONCLUSION CONCLUSIONS
This study demonstrated that the synthesized aptamers could serve as effective tools for detecting and analyzing the F1 protein, indicating their potential value in future diagnostic applications.

Identifiants

pubmed: 38829419
doi: 10.1007/s11033-024-09561-y
pii: 10.1007/s11033-024-09561-y
doi:

Substances chimiques

Aptamers, Nucleotide 0
Bacterial Proteins 0
caf1 protein, Yersinia pestis 0
Antigens, Bacterial 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

722

Informations de copyright

© 2024. The Author(s), under exclusive licence to Springer Nature B.V.

Références

Hussein MF (2021) Yersinia pestis. Infectious diseases of dromedary camels: a concise guide. Springer, pp 201–204
doi: 10.1007/978-3-030-79389-0_33
Dheyab ZS (2022) Clinically important Yersinia: minireview. J Med Health Sci 5:2295–2306
Demeure CE, Dussurget O, Mas Fiol G, Le Guern A-S, Savin C, Pizarro-Cerdá J (2019) Yersinia pestis and plague: an updated view on evolution, virulence determinants, immune subversion, vaccination, and diagnostics. Genes Immun 20:357–370. https://doi.org/10.1038/s41435-019-0065-0
doi: 10.1038/s41435-019-0065-0 pubmed: 30940874 pmcid: 6760536
Sebbane F, Uversky VN, Anisimov AP (2020) Yersinia pestis plasminogen activator. Biomolecules 10:1554. https://doi.org/10.3390/biom10111554
doi: 10.3390/biom10111554 pubmed: 33202679 pmcid: 7696990
Rosario-Acevedo R, Biryukov SS, Bozue JA, Cote CK (2021) Plague prevention and therapy: perspectives on current and future strategies. Biomedicines 9:1421. https://doi.org/10.3390/biomedicines9101421
doi: 10.3390/biomedicines9101421 pubmed: 34680537 pmcid: 8533540
Peters DT, Reifs A, Alonso-Caballero A et al (2022) Unraveling the molecular determinants of the anti-phagocytic protein cloak of plague bacteria. PLoS Pathog 18:e1010447. https://doi.org/10.1371/journal.ppat.1010447
doi: 10.1371/journal.ppat.1010447 pubmed: 35358289 pmcid: 9004762
Pohanka M, Skladal P (2009) Bacillus anthracis, Francisella tularensis and Yersinia pestis. The most important bacterial warfare agents. Folia Microbiol 54:263–272. https://doi.org/10.1007/s12223-009-0046-1
doi: 10.1007/s12223-009-0046-1
Foroshani NS, Karami A, Pourali F (2013) Simultaneous and rapid detection of Salmonella typhi, Bacillus anthracis, and Yersinia pestis by using multiplex polymerase chain reaction (PCR). Iran Red Crescent Med J. https://doi.org/10.5812/ircmj.9208
doi: 10.5812/ircmj.9208
Choi SY, Ge R, Jeon JH (2020) Development of a double-antibody sandwich ELISA for sensitive detection of Yersinia pestis. Microbiol Immunol 64:72–75. https://doi.org/10.1111/1348-0421.12751
doi: 10.1111/1348-0421.12751 pubmed: 31621104
Wei H, Zhao Y, Bi Y et al (2007) Direct detection of Yersinia pestis from the infected animal specimens by a fiber optic biosensor. Sens Actuators, B Chem 123:204–210. https://doi.org/10.1016/j.snb.2006.08.010
doi: 10.1016/j.snb.2006.08.010
Tomaso H, Thullier P, Seibold E et al (2007) Comparison of hand-held test kits, immunofluorescence microscopy, enzyme-linked immunosorbent assay, and flow cytometric analysis for rapid presumptive identification of Yersinia pestis. J Clin Microbiol 45:3404–3407
doi: 10.1128/JCM.00458-07 pubmed: 17652472 pmcid: 2045319
Jauset-Rubio M, Tomaso H, El-Shahawi MS, Bashammakh AS, Al-Youbi AO, O’Sullivan CK (2018) Duplex lateral flow assay for the simultaneous detection of Yersinia pestis and Francisella tularensis. Anal Chem 90:12745–12751. https://doi.org/10.1021/acs.analchem.8b03105
doi: 10.1021/acs.analchem.8b03105 pubmed: 30296053
Devadhasan JP, Gu J, Chen P et al (2021) Critical comparison between large and mini vertical flow immunoassay platforms for Yersinia pestis detection. Anal Chem 93:9337–9344. https://doi.org/10.1021/acs.analchem.0c05278
doi: 10.1021/acs.analchem.0c05278 pubmed: 33989499
Ke Y, Chen Z, Yang R (2013) Yersinia pestis: mechanisms of entry into and resistance to the host cell. Front Cell Infect Microbiol 3:106
doi: 10.3389/fcimb.2013.00106 pubmed: 24400226 pmcid: 3871965
Li L, Xu S, Yan H et al (2021) Nucleic acid aptamers for molecular diagnostics and therapeutics: advances and perspectives. Angew Chem Int Ed 60:2221–2231. https://doi.org/10.1002/anie.202003563
doi: 10.1002/anie.202003563
Li W, Luo Y, Gao T, Yang L, Wang J, Pei R (2019) In vitro selection of DNA aptamers for a small-molecule porphyrin by gold nanoparticle-based SELEX. J Mol Evol 87:231–239. https://doi.org/10.1007/s00239-019-09905-4
doi: 10.1007/s00239-019-09905-4 pubmed: 31432230
Lyu C, Khan IM, Wang Z (2021) Capture-SELEX for aptamer selection: a short review. Talanta 229:122274. https://doi.org/10.1016/j.talanta.2021.122274
doi: 10.1016/j.talanta.2021.122274 pubmed: 33838776
Sampson T (2003) Aptamers and SELEX: the technology. World Pat Inf 25:123–129. https://doi.org/10.1016/S0172-2190(03)00035-8
doi: 10.1016/S0172-2190(03)00035-8
Park KS (2018) Nucleic acid aptamer-based methods for diagnosis of infections. Biosens Bioelectron 102:179–188. https://doi.org/10.1016/j.bios.2017.11.028
doi: 10.1016/j.bios.2017.11.028 pubmed: 29136589
Bayat P, Nosrati R, Alibolandi M, Rafatpanah H, Abnous K, Khedri M, Ramezani M (2018) SELEX methods on the road to protein targeting with nucleic acid aptamers. Biochimie 154:132–155. https://doi.org/10.1016/j.biochi.2018.09.001
doi: 10.1016/j.biochi.2018.09.001 pubmed: 30193856
Irvine D, Tuerk C, Gold L (1991) SELEXION. Systematic evolution of ligands by exponential enrichment with integrated optimization by non-linear analysis. J Mol Biol 222:739–761. https://doi.org/10.1016/0022-2836(91)90509-5
doi: 10.1016/0022-2836(91)90509-5 pubmed: 1721092
Liu Q, Zhang W, Chen S, Zhuang Z, Zhang Y, Jiang L, Lin JS (2020) SELEX tool: a novel and convenient gel-based diffusion method for monitoring of aptamer-target binding. J Biol Eng 14:1–13. https://doi.org/10.1186/s13036-019-0223-y
doi: 10.1186/s13036-019-0223-y pubmed: 31956340 pmcid: 6956507
Wang T, Chen C, Larcher LM, Barrero RA, Veedu RN (2019) Three decades of nucleic acid aptamer technologies: lessons learned, progress and opportunities on aptamer development. Biotechnol Adv 37:28–50. https://doi.org/10.1016/j.biotechadv.2018.11.001
doi: 10.1016/j.biotechadv.2018.11.001 pubmed: 30408510
Thiviyanathan V, Gorenstein DG (2012) Aptamers and the next generation of diagnostic reagents. Proteomics—Clin Appl 6:563–573
doi: 10.1002/prca.201200042 pubmed: 23090891 pmcid: 4021847
Liu X, Zhang X (2015) Aptamer-based technology for food analysis. Appl Biochem Biotechnol 175:603–624. https://doi.org/10.1007/s12010-014-1289-0
doi: 10.1007/s12010-014-1289-0 pubmed: 25338114
Kalita JJ, Sharma P, Bora U (2022) Recent developments in application of nucleic acid aptamer in food safety. Food Control. https://doi.org/10.1016/j.foodcont.2022.109406
doi: 10.1016/j.foodcont.2022.109406
Singh R, Pal V, Tripathi N, Goel A (2020) Development of a pair of real-time loop mediated isothermal amplification assays for detection of Yersinia pestis, the causative agent of plague. Mol Cell Probes 54:101670. https://doi.org/10.1016/j.mcp.2020.101670
doi: 10.1016/j.mcp.2020.101670 pubmed: 33132200
Barbieri R, Signoli M, Chevé D et al (2020) Yersinia pestis: the natural history of plague. Clin Microbiol Rev 34:e00044-e119. https://doi.org/10.1128/cmr.00044-19
doi: 10.1128/cmr.00044-19 pubmed: 33298527 pmcid: 7920731
Pourmahdi N, Zeinoddini M, Esmatabadi MJD, Sheikhi F (2019) Simple and rapid detection of Yersinia pestis and Francisella tularensis using multiplex-PCR: molecular detection of Yersinia pestis and Francisella tularensis. Res Mol Med (RMM) https://doi.org/10.18502/rmm.v6i4.4801 .
Riedel S (2005) Plague: from natural disease to bioterrorism. In: Baylor University Medical Center proceedings, Taylor & Francis, pp 116–124. https://doi.org/10.1080/08998280.2005.11928049 .
Kumar Kulabhusan P, Hussain B, Yüce M (2020) Current perspectives on aptamers as diagnostic tools and therapeutic agents. Pharmaceutics 12:646. https://doi.org/10.3390/pharmaceutics12070646
doi: 10.3390/pharmaceutics12070646 pubmed: 32659966 pmcid: 7407196
Kooshki H, Abbaszadeh R, Heidari R et al (2019) Developing a DNA aptamer-based approach for biosensing cystatin-c in serum: an alternative to antibody-based methods. Anal Biochem 584:113386. https://doi.org/10.1016/j.ab.2019.113386
doi: 10.1016/j.ab.2019.113386 pubmed: 31390526
Wang T, Yin W, AlShamaileh H et al (2019) A detailed protein-SELEX protocol allowing visual assessments of individual steps for a high success rate. Hum Gene Ther Methods 30:1–16
doi: 10.1089/hgtb.2018.237 pubmed: 30700146
Lakhin A, Tarantul V, Gening L (2013) Aptamers: problems, solutions and prospects. Acta Naturae (aнглoязычнaя вepcия) 5:34–43
doi: 10.32607/20758251-2013-5-4-34-43
Cutts ZW, Hong JM, Shao S et al (2022) Target-switch SELEX: screening with alternating targets to generate aptamers to conserved terminal dipeptides. STAR Protoc 3:101724. https://doi.org/10.1016/j.xpro.2022.101724
doi: 10.1016/j.xpro.2022.101724 pubmed: 36208449 pmcid: 9557731
McKeague M, McConnell EM, Cruz-Toledo J et al (2015) Analysis of in vitro aptamer selection parameters. J Mol Evol 81:150–161. https://doi.org/10.1007/s00239-015-9708-6
doi: 10.1007/s00239-015-9708-6 pubmed: 26530075
Kohlberger M, Gadermaier G (2022) SELEX: Critical factors and optimization strategies for successful aptamer selection. Biotechnol Appl Biochem 69:1771–1792
doi: 10.1002/bab.2244 pubmed: 34427974
Sun S, Liu H, Hu Y et al (2023) Selection and identification of a novel ssDNA aptamer targeting human skeletal muscle. Bioact Mater 20:166–178. https://doi.org/10.1016/j.bioactmat.2022.05.016
doi: 10.1016/j.bioactmat.2022.05.016 pubmed: 35663338
Nur Y, Gaffar S, Hartati YW, Subroto T (2021) Applications of electrochemical biosensor of aptamers-based (APTASENSOR) for the detection of leukemia biomarker. Sens Bio-Sens Res 32:100416. https://doi.org/10.1016/j.sbsr.2021.100416
doi: 10.1016/j.sbsr.2021.100416
Ouellet E, Foley JH, Conway EM, Haynes C (2015) Hi-Fi SELEX: a high-fidelity digital-PCR based therapeutic aptamer discovery platform. Biotechnol Bioeng 112:1506–1522. https://doi.org/10.1002/bit.25581
doi: 10.1002/bit.25581 pubmed: 25727321
Song J, Zheng Y, Huang M et al (2019) A sequential multidimensional analysis algorithm for aptamer identification based on structure analysis and machine learning. Anal Chem 92:3307–3314. https://doi.org/10.1002/bit.25581
doi: 10.1002/bit.25581
Mousivand M, Anfossi L, Bagherzadeh K, Barbero N, Mirzadi-Gohari A, Javan-Nikkhah M (2020) In silico maturation of affinity and selectivity of DNA aptamers against aflatoxin B1 for biosensor development. Anal Chim Acta 1105:178–186. https://doi.org/10.1016/j.aca.2020.01.045
doi: 10.1016/j.aca.2020.01.045 pubmed: 32138917
Navien TN, Thevendran R, Hamdani HY, Tang T-H, Citartan M (2021) In silico molecular docking in DNA aptamer development. Biochimie 180:54–67. https://doi.org/10.1016/j.biochi.2020.10.005
doi: 10.1016/j.biochi.2020.10.005 pubmed: 33086095
Yue H, Chen J, Chen X, Wang X, Zhang Y, Zhou N (2021) Systematic screening and optimization of single-stranded DNA aptamer specific for N-acetylneuraminic acid: a comparative study. Sens Actuators, B Chem 344:130270. https://doi.org/10.1016/j.snb.2021.130270
doi: 10.1016/j.snb.2021.130270
Zhao L, Qi X, Yan X et al (2019) Engineering aptamer with enhanced affinity by triple helix-based terminal fixation. J Am Chem Soc 141:17493–17497. https://doi.org/10.1021/jacs.9b09292
doi: 10.1021/jacs.9b09292 pubmed: 31609609
Kuai H, Zhao Z, Mo L et al (2017) Circular bivalent aptamers enable in vivo stability and recognition. J Am Chem Soc 139:9128–9131. https://doi.org/10.1021/jacs.7b04547
doi: 10.1021/jacs.7b04547 pubmed: 28635257 pmcid: 5877791
Azri FA, Selamat J, Sukor R et al (2021) Determination of minimal sequence for zearalenone aptamer by computational docking and application on an indirect competitive electrochemical aptasensor. Anal Bioanal Chem 413:3861–3872. https://doi.org/10.1007/s00216-021-03336-1
doi: 10.1007/s00216-021-03336-1 pubmed: 34021369
Prentice KW, DePalma L, Ramage JG et al (2019) Comprehensive laboratory evaluation of a lateral flow assay for the detection of Yersinia pestis. Health Secur 17:439–453. https://doi.org/10.1089/hs.2019.0094
doi: 10.1089/hs.2019.0094 pubmed: 31859568 pmcid: 6964806
Randriantseheno LN, Rahantamalala A, Randrianierenana AL, Rajerison M, Andrianaivoarimanana V (2020) Development and evaluation of loop-mediated isothermal amplification for detection of Yersinia pestis in plague biological samples. PLoS ONE 15:e0237655. https://doi.org/10.1371/journal.pone.0237655
doi: 10.1371/journal.pone.0237655 pubmed: 32810167 pmcid: 7437451
Christensen DR, Hartman LJ, Loveless BM et al (2006) Detection of biological threat agents by real-time PCR: comparison of assay performance on the RAPID, the LightCycler, and the smart cycler platforms. Clin Chem 52:141–145. https://doi.org/10.1373/clinchem.2005.052522
doi: 10.1373/clinchem.2005.052522 pubmed: 16391330

Auteurs

Nafiseh Shafiei (N)

Department of Biology, Science and Research Branch, Islamic Azad University, Tehran, Iran.

Hamideh Mahmoodzadeh Hosseini (H)

Applied Microbiology Research Center, Biomedicine Technologies Institute, Baqiyatallah University of Medical Sciences, Tehran, Iran. hosseini361@yahoo.com.

Jafar Amani (J)

Applied Microbiology Research Center, Biomedicine Technologies Institute, Baqiyatallah University of Medical Sciences, Tehran, Iran.

Seyed Ali Mirhosseini (SA)

Applied Microbiology Research Center, Biomedicine Technologies Institute, Baqiyatallah University of Medical Sciences, Tehran, Iran.

Hanieh Jafary (H)

Department of Biology, Science and Research Branch, Islamic Azad University, Tehran, Iran.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH